Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 8
Submit an article Journal homepage
420
Views
14
CrossRef citations to date
0
Altmetric
Infection

New antibiotics for the treatment of serious infections in intensive care unit patients

Sebastiano LeoneDivision of Infectious Diseases, “San Giuseppe Moscati” Hospital, Avellino, Italy; ORCID Iconhttp://orcid.org/0000-0001-7852-4101
ORCID Icon,
Marco CascellaDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5236-3132
ORCID Icon,
Ilaria PezoneDepartment of Pediatrics, “San Giuseppe Moscati” Hospital, Naples, Italy; ORCID Iconhttp://orcid.org/0000-0001-9167-4657
ORCID Icon &
Marco FioreDepartment of Women Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Naples, ItalyORCID Iconhttp://orcid.org/0000-0001-7263-0229
ORCID Icon
Pages 1331-1334 | Received 14 Nov 2018, Accepted 12 Feb 2019, Published online: 22 Mar 2019

References

  • Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–2329.
  • Esposito S, Leone S. Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents. 2007;29:494–500.
  • Fiore M, Taccone FS, Leone S. Choosing the appropriate pharmacotherapy for multidrug-resistant Gram positive infections. Expert Opin Pharmacother. 2018;19:1517–1521.
  • Maraolo AE, Cascella M, Corcione S, et al. Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art. Expert Rev Anti Infect Ther. 2017;15:861–871.
  • Scott LJ. Ceftaroline fosamil: a review in complicated skin and soft tissue infections and community-acquired pneumonia. Drugs. 2016;76:1659–1674.
  • Leone S, Noviello S, Boccia G, et al. Methicillin-resistant Staphylococcus aureus infections: role of daptomycin/β-lactams combination. Infez Med. 2015;23–99–104.
  • Leone S, Noviello S, Esposito S. Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci. Infection. 2016;44:273–281.
  • Abbas M, Paul M, Huttner A. New and improved? A review of novel antibiotics for Gram-positive bacteria. Clin Microbiol Infect. 2017;23:697–703.
  • Wright H, Bonomo RA, Paterson DL. New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn? Clin Microbiol Infect. 2017;23:704–712.
  • Liscio JL, Mahoney MV, Hirsch EB. Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections. Int J Antimicrob Agents. 2015;46:266–271.
  • Petty LA, Henig O, Patel TS, et al. Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae. IDR. 2018;11:1461–1472.
  • Burdette SD, Trotman R. Tedizolid: the first once-daily oxazolidinone class antibiotic. Clin Infect Dis. 2015;61:1315–1321.
  • Mikamo H, Takesue Y, Iwamoto Y, et al. Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan – results of a randomised, multicentre phase 3 study. J Infect Chemother. 2018;24:434–442.
  • Lin SY, Huang CH, Ko WC, et al. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections. Expert Opin Pharmacother. 2016;17:339–354.
  • Noviello S, Ianniello F, Leone S, et al. In vitro activity of tigecycline: MICs, MBCs, time-kill curves and post-antibiotic effect. J Chemother. 2008;20:577–580.
  • Mo Y, Lorenzo M, Farghaly S, et al. What’s new in the treatment of multidrug-resistant gram-negative infections? Diagn Microbiol Infect Dis. 2019;93:171–181.
  • Mckinnell JA, Connolly LE, Pushkin R, et al. Improved outcomes with plazomicin (PLZ) compared with colistin (CST) in patients with bloodstream infections (BSI) caused by carbapenem-resistant Enterobacteriaceae (CRE): results from the CARE study. Open Forum Infect Dis. 2017;4:S531.
  • Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033.
  • Esposito S, Noviello S, Leone S. Dalbavancin for the treatment of acute bacterial skin and skin structure infections. Infez Med. 2015;23:313–1317.
  • Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study. J Chemother. 2009;21:193–198.
  • Tobudic S, Forstner C, Burgmann H, et al. Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the General Hospital of Vienna. Clin Infect Dis. 2018;67:795–798.
  • David MZ, Dryden M, Gottlieb T, et al. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new. Int J Antimicrob Agents. 2017;50:303–307.
  • Zhanel GG, Calic D, Schweizer F, et al. New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin. Drugs. 2010;70:859–886.
  • Saravolatz LD, Stein GE. Delafloxacin: a new anti-methicillin-resistant Staphylococcus aureus Fluoroquinolone. Clin Infect Dis. 2019;68:1058–1062.
  • Pfaller MA, Sader HS, Rhomberg PR, et al. In vitro activity of delafloxacin against contemporary bacterial pathogens from the United States and Europe, 2014. Antimicrob Agents Chemother. 2017;61:e02609–e02616.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.